Precision Medicine Intervention in Severe Asthma (PRISM) Study
NCT05164939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-12-21
Summary
The Korea-UK Precision Medicine Intervention in Severe Asthma (PRISM) study aims to identify molecular phenotypes of severe asthma by analyzing multi-omics data including genomics, epigenomics, transcriptomics, proteomics, metagenomics, and metabolomics.
Conditions
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Tae-Bum Kim · Asan Medical Center
-
Kian Fan Chung · Imperial College London
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- South Korea
- United Kingdom
Study Locations
More Related Trials
-
Study of the Mechanisms of Asthma
NCT00595153 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of SA09012 in Asthma
NCT01740986 ·Status: COMPLETED ·Phase: PHASE2
-
Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting
NCT03595930 ·Status: COMPLETED
-
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03988790 ·Status: UNKNOWN ·Phase: NA
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China
NCT02143739 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT00784953 ·Status: COMPLETED
-
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 ·Status: TERMINATED ·Phase: PHASE1
-
Breath Analysis in Asthma
NCT02450461 ·Status: COMPLETED
-
Asthma Control in Elderly Patients With Montelukast
NCT01147510 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
NCT06015256 ·Status: RECRUITING ·Phase: NA
-
MISSION Severe Asthma Modern Innovative Solutions to Improve Outcomes in Severe Asthma.
NCT02509130 ·Status: COMPLETED
-
Study on Patterns of Care in Mild Asthmatic Patients
NCT04598555 ·Status: COMPLETED
-
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679 ·Status: COMPLETED
-
Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
NCT00480649 ·Status: COMPLETED ·Phase: PHASE4
-
US PRECISION Implementation Study
NCT04891978 ·Status: COMPLETED ·Phase: NA
-
The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma
NCT05750797 ·Status: UNKNOWN
-
Remission in Adults With Severe Asthma in Thailand
NCT07328035 ·Status: RECRUITING
-
Identification of Asthma Phenotypes in Severe Asthmatics
NCT01623089 ·Status: RECRUITING
-
Severe Asthma Covid Vaccine Response Study
NCT05130320 ·Status: UNKNOWN
-
Association Between Fractional Exhaled Nitric Oxide and Asthma Control
NCT01197690 ·Status: COMPLETED
-
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
NCT05018299 ·Status: RECRUITING ·Phase: PHASE2
-
Taiwan Severe Asthma Biologic Registry
NCT06456450 ·Status: RECRUITING
-
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
NCT04714567 ·Status: UNKNOWN